A study conducted by a Foundation-funded research team at the University of Pennsylvania serves as stepping stone to a clinical trial.

World-renowned as an eye expert, and revered as an academic leader, Dr. Ryan was a staunch advocate for retinal research.

New study results lead to recommendation for replacing beta carotene with lutein and zeaxanthin in AREDS supplement.

The California-based company Advanced Cell Technology is conducting clinical trials for patients with Stargardt disease and dry AMD.